217 related articles for article (PubMed ID: 38239860)
1. Circulating tumor cells in colorectal cancer - a review of detection methods and clinical relevance.
Saadi S; Aarab M; Tabyaoui I; Jouti NT
Contemp Oncol (Pozn); 2023; 27(3):123-131. PubMed ID: 38239860
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility.
Petrik J; Verbanac D; Fabijanec M; Hulina-Tomašković A; Čeri A; Somborac-Bačura A; Petlevski R; Grdić Rajković M; Rumora L; Krušlin B; Štefanović M; Ljubičić N; Baršić N; Hanžek A; Bočkor L; Ćelap I; Demirović A; Barišić K
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362369
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
Abdalla TSA; Meiners J; Riethdorf S; König A; Melling N; Gorges T; Karstens KF; Izbicki JR; Pantel K; Reeh M
PLoS One; 2021; 16(6):e0252897. PubMed ID: 34111181
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
8. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
Steinert G; Schölch S; Koch M; Weitz J
Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
[TBL] [Abstract][Full Text] [Related]
9. Synergistic diagnostic value of circulating tumor cells and tumor markers CEA/CA19-9 in colorectal cancer.
Cai M; He H; Hong S; Weng J
Scand J Gastroenterol; 2023 Jan; 58(1):54-60. PubMed ID: 35968572
[TBL] [Abstract][Full Text] [Related]
10. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.
Liu Z; Gu Y; Yu F; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Qian W; Li X
Evid Based Complement Alternat Med; 2022; 2022():4162354. PubMed ID: 36193123
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
Hou J; Guo C; Lyu G
Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis.
He Y; He X; Zhou Y; Luo S
BMC Cancer; 2023 Jul; 23(1):707. PubMed ID: 37507669
[TBL] [Abstract][Full Text] [Related]
15. Enhanced prognostic value of combined circulating tumor cells and serum carcinoembryonic antigen in patients with colorectal cancer.
Yang CY; Lin CC; Huang SC; Lu RH; Lo LC; Tseng JY; Tung CY; Lin CH; Jiang JK
J Chin Med Assoc; 2023 May; 86(5):465-471. PubMed ID: 36821465
[TBL] [Abstract][Full Text] [Related]
16. Detection and clinical significance of circulating tumor cells in colorectal cancer.
Jiang M; Jin S; Han J; Li T; Shi J; Zhong Q; Li W; Tang W; Huang Q; Zong H
Biomark Res; 2021 Nov; 9(1):85. PubMed ID: 34798902
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD133
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in different stages of colorectal cancer.
Eliasova P; Pinkas M; Kolostova K; Gurlich R; Bobek V
Folia Histochem Cytobiol; 2017; 55(1):1-5. PubMed ID: 28509310
[TBL] [Abstract][Full Text] [Related]
19. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
20. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
